Obinutuzumab: a new class of anti-CD20 monoclonal antibody. (Q38228447)
Jump to navigation
Jump to search
scientific article published on September 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Obinutuzumab: a new class of anti-CD20 monoclonal antibody. |
scientific article published on September 2014 |
Statements
Obinutuzumab: a new class of anti-CD20 monoclonal antibody (English)
Anne-Laure Gagez
1 reference
Guillaume Cartron
1 reference